Literature DB >> 33433463

Induced pluripotent stem cell technology for spinal cord injury: a promising alternative therapy.

Yu Li1, Ping-Ping Shen2, Bin Wang3.   

Abstract

Spinal cord injury has long been a prominent challenge in the trauma repair process. Spinal cord injury is a research hotspot by virtue of its difficulty to treat and its escalating morbidity. Furthermore, spinal cord injury has a long period of disease progression and leads to complications that exert a lot of mental and economic pressure on patients. There are currently a large number of therapeutic strategies for treating spinal cord injury, which range from pharmacological and surgical methods to cell therapy and rehabilitation training. All of these strategies have positive effects in the course of spinal cord injury treatment. This review mainly discusses the problems regarding stem cell therapy for spinal cord injury, including the characteristics and action modes of all relevant cell types. Induced pluripotent stem cells, which represent a special kind of stem cell population, have gained impetus in cell therapy development because of a range of advantages. Induced pluripotent stem cells can be developed into the precursor cells of each neural cell type at the site of spinal cord injury, and have great potential for application in spinal cord injury therapy.

Entities:  

Keywords:  axon regeneration; cell therapy; functional recovery; induced pluripotent stem cell; mesenchymal stem cell; neural cells; neural precursor cell; neural stem cell; remyelination; spinal cord injury; stem cells

Year:  2021        PMID: 33433463     DOI: 10.4103/1673-5374.303013

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   5.135


  5 in total

Review 1.  Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms.

Authors:  Atefeh Zarepour; Sara Hooshmand; Aylin Gökmen; Ali Zarrabi; Ebrahim Mostafavi
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

2.  Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury.

Authors:  Ting-Ting Cao; Huan Chen; Mao Pang; Si-Si Xu; Hui-Quan Wen; Bin Liu; Li-Min Rong; Mang-Mang Li
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

3.  Stem Cell Therapy for Neuropathic Pain: A Bibliometric and Visual Analysis.

Authors:  Houming Kan; Lijun Fan; Xiaodie Gui; Xiaoqiang Li; Sen Yang; Yuting Huang; Liping Chen; Wen Shen
Journal:  J Pain Res       Date:  2022-06-23       Impact factor: 2.832

4.  Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Promotes Forelimb Functional Recovery after Cervical Spinal Cord Injury.

Authors:  Yiyan Zheng; Chrystine M Gallegos; Haipeng Xue; Shenglan Li; Dong H Kim; Hongxia Zhou; Xugang Xia; Ying Liu; Qilin Cao
Journal:  Cells       Date:  2022-09-05       Impact factor: 7.666

Review 5.  Advances and Perspectives in Dental Pulp Stem Cell Based Neuroregeneration Therapies.

Authors:  Jon Luzuriaga; Yurena Polo; Oier Pastor-Alonso; Beatriz Pardo-Rodríguez; Aitor Larrañaga; Fernando Unda; Jose-Ramon Sarasua; Jose Ramon Pineda; Gaskon Ibarretxe
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.